Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Forte Biosciences Inc
(NQ:
FBRX
)
7.700
-0.030 (-0.39%)
Streaming Delayed Price
Updated: 2:59 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Forte Biosciences Inc
< Previous
1
2
3
4
Next >
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
September 08, 2021
From
The Schall Law Firm
Via
Business Wire
72 Biggest Movers From Yesterday
September 08, 2021
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth....
Via
Benzinga
Unusual Options Activity Insight: Forte Biosciences
August 06, 2021
On Friday, shares of Forte Biosciences (NASDAQ:FBRX) saw u...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 07, 2021
Gainers Surrozen (NASDAQ:SRZN) stock rose 33.14% to $9.64 during Tuesday's regular session. The company's market cap stands at $351.2 million. ZIOPHARM Oncology (...
Via
Benzinga
53 Biggest Movers From Friday
September 07, 2021
Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform. Vera...
Via
Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
September 06, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
5 Value Stocks In The Healthcare Sector
September 06, 2021
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week
September 05, 2021
Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday...
Via
Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors With Losses to Contact the Firm
September 03, 2021
From
The Schall Law Firm
Via
Business Wire
Mid-Afternoon Market Update: Crude Oil Down 1%; MongoDB Shares Jump After Q2 Results
September 03, 2021
Toward the end of trading Friday, the Dow traded down 0.11% to 35,403.67 while the NASDAQ rose 0.23% to 15,366.71. The S&P also rose, gaining 0.04% to 4,538.92. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Forte Biosciences Stock Is Down Over 80% Today
September 03, 2021
Forte Biosciences (NASDAQ: FBRX) is tanking today after the company announced the clinical trial of FB-401 for the treatment of atopic dermatitis failed to meet statistical...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 03, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP
Via
Benzinga
Dow Steps Back, Nasdaq Reaches For More Records
September 03, 2021
The Dow Jones Industrial Index is taking a breather today, last seen down 56 points, after August's jobs report came in much lower than expected.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Mid-Day Market Update: Gold Rises 1%; Forte Biosciences Shares Plunge
September 03, 2021
Midway through trading Friday, the Dow traded down 0.23% to 35,361.40 while the NASDAQ rose 0.02% to 15,333.95. The S&P also fell, dropping 0.22% to 4,527.17. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
35 Stocks Moving In Friday's Mid-Day Session
September 03, 2021
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 35% to $7.43. Cellect Biotechnology announced the first ApoGraft transplantation in a Leukemia patient in a...
Via
Benzinga
Why Forte Biosciences Stock Is Imploding Today
September 03, 2021
The company announced dismal results from a phase 2 study of its only pipeline candidate.
Via
The Motley Fool
Mid-Morning Market Update: Markets Mostly Lower; US Economy Adds 235,000 Jobs In August
September 03, 2021
Following the market opening Friday, the Dow traded down 0.41% to 35,300.08 while the NASDAQ rose 0.02% to 15,334.73. The S&P also fell, dropping 0.25% to 4,525.66. The U.S....
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 03, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP) shares rose 68.9% to $9.29 during Friday's pre-market session. The company's market cap stands at $36.4 million....
Via
Benzinga
20 Stocks Moving in Friday's Pre-Market Session
September 03, 2021
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 59.5% to $8.77 in pre-market trading after the company announced the ApoGraft bone marrow transplantation of the first...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Rise; All Eyes On Jobs Report
September 03, 2021
Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of the release of jobs report for August. Analysts expect nonfarm payrolls rising 740,000 for...
Via
Benzinga
Forte Biosciences Just Plummeted 80%: Here's Why
September 02, 2021
A biopharmaceutical company focused on the development of dermatology treatments saw a sharp drop after hours Thursday. What Happened: The clinical trial of Forte Biosciences (...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 02, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP
Via
Benzinga
Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance
September 02, 2021
From
Forte Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 18, 2021
Gainers Protagenic Therapeutics (NASDAQ:PTIX...
Via
Benzinga
48 Stocks Moving In Tuesday's Mid-Day Session
August 17, 2021
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA...
Via
Benzinga
66 Biggest Movers From Yesterday
August 18, 2021
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 17, 2021
Gainers Forte Biosciences (NASDAQ:FBRX) stock increased by 16.38% to $27.7 during Tuesday's pre-market session. The market value of their outstanding shares is at $374...
Via
Benzinga
25 Stocks Moving in Tuesday's Pre-Market Session
August 17, 2021
Gainers Cardiol Therapeutics Inc. (NASDAQ: CRDL) shares rose 25.8% to $3.27 in pre-market trading after dropping around 7% on Monday. LM Funding America, Inc. (NASDAQ: LMFA) rose...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 16, 2021
Gainers Strata Skin Sciences (NASDAQ:SSKN
Via
Benzinga
Forte Biosciences, Inc. to Review the Second Quarter 2021 Results and Expects to Announce Topline Data From Phase 2 Clinical Trial of FB-401 for the Treatment of Atopic Dermatitis on Sept. 7
August 16, 2021
From
Forte Biosciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.